Commentary: One-Year Outcomes of First-Line Therapeutic Strategies in Critical Limb Ischemia: Are We Anywhere Near the Truth?

Rush. Hold Your Fire. 1987: Polygram/Mercury; lyrics by Neil Peart, Geddy Lee Weinrib, and Alex Zivojinovich.

Mustapha JA Diaz-Sandoval LJ. Plaque composition in the proximal SFA and clinical outcomes in patients with claudication. Have we found the answer? JACC Cardiovasc Imaging. 2017;10:1013–1015.

Gray BH Diaz-Sandoval LJ Dieter RS et al . SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use. Catheter Cardiovasc Interv. 2014;84:539–545.

Mustapha JA Saab F Diaz-Sandoval LJ. Inframalleolar interventions in critical limb ischemia: trailblazing the path toward the final frontier? JACC Cardiovasc Interv. 2017;10:91–93.

Katsanos K Spiliopoulos S Paraskevopoulos I et al . Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability. J Endovasc Ther. 2016;23:356–370.

Katsanos K Spiliopoulos S Karunanithy N et al . Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery. J Vasc Surg. 2014;59:1123–1133.e8.

Zeller T Baumgartner I Scheinert D et al . Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol. 2014;64:1568–1576.

Katsanos K Kitrou P Spiliopoulos S et al . Comparative effectiveness of plain balloon angioplasty, bare metal stents, drug-coated balloons, and drug-eluting stents for the treatment of infrapopliteal artery disease: systematic review and Bayesian network meta-analysis of randomized controlled trials. J Endovasc Ther. 2016;23:851–863.

Cassar K Bachoo P Ford I et al . Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg. 2005;29:171–176.

Laird JR Katzen BT Scheinert D et al . Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther. 2012;19:1–9.

Duda SH Bosiers M Lammer J et al . Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701–710.

Ní Ghriallais R Heraty K Smouse B et al . Deformation of the femoropopliteal segment: effect of stent length, location, flexibility, and curvature. J Endovasc Ther. 2016;23:907–918.

Laird JR. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther. 2006;13(suppl 2):II30–II40.

Palena LM Diaz-Sandoval LJ Sultato E et al . Feasibility and 1-year outcomes of subintimal revascularization with Supera stenting of long femoropopliteal occlusions in critical limb ischemia: The “SUPERSUB” study. Catheter Cardiovasc Interv. 2017;89:910–920.

Rocha-Singh KJ Jaff MR Crabtree TR et al; VIVA Physicians, Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69:910–919.

Razavi MK Mustapha JA Miller LE. Contemporary systematic review and meta-analysis of early outcomes with percutaneous treatment for infrapopliteal atherosclerotic disease. J Vasc Interv Radiol. 2014;25:1489–1496.

Romiti M Albers M Brochado-Neto FC et al . Metaanalysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47:975–981.

Mustapha JA Finton SM Diaz-Sandoval LJ et al . Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease. Systematic review and meta-analysis. Circ Cardiovasc Interv. 2016;9:e003468.

TASC Steering Committee, Jaff MR White CJ et al . An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Endovasc Ther. 2015;22:663–677.

Stavroulakis K Borowski M Torsello G et al; CRITISCH Collaborators. One-year results of first-line treatment strategies in patients with critical limb ischemia (CRITISCH registry). J Endovasc Ther. 2018;25:320–329.

Bisdas T Borowski M Stavroulakis K et al ; CRITISCH Collaborators. Endovascular therapy versus bypass surgery as first-line treatment strategies for critical limb ischemia: results of the interim analysis of the CRITISCH registry. JACC Cardiovasc Interv. 2016;9:2557–2565.

Goodney PP Travis LL Nallamothu BK et al . Variation in the use of lower extremity vascular procedures for critical limb ischemia. Circ Cardiovasc Qual Outcomes. 2012;5:94–102.

Yost ML. Cost benefit analysis of critical limb ischemia in the era of the Affordable Care Act. Endovascular Today. 2014;(5):29–36.